EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Applying the Argument-Based Approach to Validation With Clinical Outcome Assessments: Strategies for Constructing a Rationale

Kevin P Weinfurt, R J Wirth, Michael C Edwards, Bryce B Reeve

Value in Health · 2026

DOI: 10.1016/j.jval.2026.01.007 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Value in Health, 2026. Verfasst von Kevin P Weinfurt und 3 weiteren Autor:innen. Beteiligte Einrichtung: Center for Health Measurement, Department of Population Health Sciences, Duke University School of Medicine, Durham, North Carolina, USA. Electronic …. Hauptthemen laut MEDLINE: Drug Development, Outcome Assessment, Health Care. Die Arbeit nennt 11 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: US Food and Drug Administration White Oak Campus.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The argument-based approach to validation, adopted in the US Food and Drug Administration's most recent Patient-Focused Drug Development draft guidance on clinical outcome assessments (COAs), emphasizes the importance of constructing explicit rationales to support proposed interpretations of COA scores. To assist researchers and sponsors in building such rationales, we describe 2 complementary strategies: (1) reviewing steps in the assessment process to identify essential assumptions and (2) evaluating potential threats to validity from construct underrepresentation and construct irrelevance. Using these strategies, we offer initial generic rationales tailored to 4 types of COAs: patient-reported outcomes (PROs), observer-reported outcomes (ObsROs), clinician-reported outcomes (ClinROs), and performance outcome (PerfO) measures. The generic rationales serve as starting points, with the expectation that they will be adapted to specific contexts of use. Greater discussion within the field is needed to advance consensus on the construction and evaluation of evidence-based rationales, with attention to the pragmatic and iterative nature of validation work.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug DevelopmentOutcome Assessment, Health CareHumansPatient Reported Outcome MeasuresUnited StatesUnited States Food and Drug AdministrationReproducibility of ResultsResearch Design

Stichwörter der Autor:innen

clinical outcome assessmentsfit-for-purposemeasurementpatient-focused drug developmentvalidity

Autor:innen und Institutionen

  • Center for Health Measurement, Department of Population Health Sciences, Duke University School of Medicine, Durham, North Carolina, USA. Electronic address: kevin.weinfurt@duke.edu.
  • Vector Psychometric Group, LLC, Chapel Hill, North Carolina, USA.
  • Vector Psychometric Group, LLC, Chapel Hill, North Carolina, USA; Department of Psychology, Arizona State University, Tempe, Arizona, USA.
  • Center for Health Measurement, Department of Population Health Sciences, Duke University School of Medicine, Durham, North Carolina, USA.

Förderung

  • US Food and Drug Administration White Oak Campus

Zitieren

APA

Weinfurt, K. P., Wirth, R. J., Edwards, M. C., & Reeve, B. B. (2026). Applying the Argument-Based Approach to Validation With Clinical Outcome Assessments: Strategies for Constructing a Rationale. Value in Health. https://doi.org/10.1016/j.jval.2026.01.007

Vancouver

Weinfurt KP, Wirth RJ, Edwards MC, Reeve BB. Applying the Argument-Based Approach to Validation With Clinical Outcome Assessments: Strategies for Constructing a Rationale. Value in Health. 2026. doi:10.1016/j.jval.2026.01.007

BibTeX
@article{Weinfurt2026,
  author = {Weinfurt, Kevin P and Wirth, R J and Edwards, Michael C and Reeve, Bryce B},
  title = {Applying the Argument-Based Approach to Validation With Clinical Outcome Assessments: Strategies for Constructing a Rationale},
  journal = {Value in Health},
  year = {2026},
  doi = {10.1016/j.jval.2026.01.007}
}
Kostenlos starten →